Published in PLoS One on July 02, 2008
Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer (2011) 5.12
MicroRNAs in cancer. Annu Rev Pathol (2013) 3.50
miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res (2010) 2.75
MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer (2009) 2.57
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer (2010) 2.51
Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood (2008) 2.36
Retracted MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem (2010) 2.34
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer (2010) 2.33
A 3'-untranslated region (3'UTR) induces organ adhesion by regulating miR-199a* functions. PLoS One (2009) 2.24
The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol (2010) 2.20
miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One (2010) 2.15
Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases. Mol Cancer (2010) 2.14
A microRNA expression signature for cervical cancer prognosis. Cancer Res (2010) 2.14
MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. PLoS One (2009) 1.88
miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS One (2009) 1.84
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ (2009) 1.82
Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol (2010) 1.80
miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS One (2013) 1.75
Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer (2010) 1.69
Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol Med (2011) 1.68
MicroRNA profiling and head and neck cancer. Comp Funct Genomics (2009) 1.68
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One (2012) 1.67
MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One (2010) 1.64
Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA (2009) 1.60
Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. PLoS One (2010) 1.59
Melanoma MicroRNA signature predicts post-recurrence survival. Clin Cancer Res (2010) 1.59
The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer. J Hematol Oncol (2012) 1.56
Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. PLoS Pathog (2009) 1.53
A putative role for microRNA-205 in mammary epithelial cell progenitors. J Cell Sci (2010) 1.47
MicroRNA expression variability in human cervical tissues. PLoS One (2010) 1.47
Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci (2010) 1.45
Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol (2010) 1.45
MicroRNAs: critical mediators of differentiation, development and disease. Swiss Med Wkly (2009) 1.43
Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer (2011) 1.42
Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta (2011) 1.40
Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck (2011) 1.40
Retracted: Luciferase-transfected colon adenocarcinoma cell line (DLD-1) for use in Orthotopic Xenotransplantation studies. Chem Cent J (2012) 1.39
MicroRNA-146a inhibits glioma development by targeting Notch1. Mol Cell Biol (2011) 1.36
MiR-27 as a prognostic marker for breast cancer progression and patient survival. PLoS One (2012) 1.35
Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucleic Acids Res (2014) 1.34
Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol (2010) 1.33
Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology (2010) 1.31
MiR-146a in Immunity and Disease. Mol Biol Int (2011) 1.28
Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization. J Transl Med (2011) 1.27
Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer (2012) 1.26
microRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci U S A (2014) 1.25
MicroRNA regulation in Ames dwarf mouse liver may contribute to delayed aging. Aging Cell (2009) 1.24
MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling. Cancer Res (2012) 1.24
Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation. J Cancer Res Clin Oncol (2011) 1.23
MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas. J Oral Maxillofac Res (2013) 1.22
The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer. Br J Cancer (2012) 1.20
Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas. Am J Physiol Heart Circ Physiol (2010) 1.20
Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma. Int J Oncol (2013) 1.19
A combination of Let-7d, Let-7g and Let-7i serves as a stable reference for normalization of serum microRNAs. PLoS One (2013) 1.16
miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells. Mol Cancer (2014) 1.16
Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. Diagn Pathol (2013) 1.16
The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer. RNA Biol (2010) 1.15
miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS One (2012) 1.15
MicroRNA-143 inhibits migration and invasion of human non-small-cell lung cancer and its relative mechanism. Int J Biol Sci (2013) 1.13
Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS One (2011) 1.13
Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population. World J Gastroenterol (2010) 1.11
Human papillomavirus 16 E5 modulates the expression of host microRNAs. PLoS One (2011) 1.11
Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS One (2011) 1.09
Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer. J Cancer (2014) 1.09
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome. Blood (2011) 1.08
MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways. J Cell Mol Med (2014) 1.08
NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia. Leukemia (2014) 1.07
MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. PLoS One (2012) 1.06
Pharmacological studies of the mechanism and function of interleukin-1beta-induced miRNA-146a expression in primary human airway smooth muscle. Respir Res (2010) 1.05
Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci (2010) 1.05
Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer. Nat Commun (2013) 1.03
MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma. FEBS Lett (2010) 1.03
Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. Int J Clin Exp Pathol (2015) 1.02
Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expression. Cell Death Dis (2013) 1.01
Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway. Int J Cancer (2011) 1.01
MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma. BMC Cancer (2014) 1.01
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC. Int J Oncol (2012) 1.00
MicroRNAs and lung cancers: from pathogenesis to clinical implications. Front Med (2012) 1.00
Potentially predictive microRNAs of gastric cancer with metastasis to lymph node. World J Gastroenterol (2011) 0.99
Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases. Front Cell Dev Biol (2014) 0.99
Increased exosomal microRNA-21 and microRNA-146a levels in the cervicovaginal lavage specimens of patients with cervical cancer. Int J Mol Sci (2014) 0.98
Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways. PLoS One (2013) 0.98
Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer. J Cancer Res Clin Oncol (2010) 0.98
Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1α. Nucleic Acids Res (2014) 0.98
MiR-15b targets cyclin D1 to regulate proliferation and apoptosis in glioma cells. Biomed Res Int (2014) 0.98
Small molecule inhibitors of human papillomavirus protein - protein interactions. Open Virol J (2011) 0.97
Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathog (2015) 0.97
Down-regulation of miR-129-5p inhibits growth and induces apoptosis in laryngeal squamous cell carcinoma by targeting APC. PLoS One (2013) 0.96
miRNAs in the pathogenesis of oncogenic human viruses. Cancer Lett (2010) 0.96
Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review). Oncol Rep (2014) 0.96
Identification of non-coding RNAs embracing microRNA-143/145 cluster. Mol Cancer (2010) 0.96
Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis. Cancer Cell Int (2015) 0.96
microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer (2012) 0.95
Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways. Front Genet (2013) 0.94
Minireview: The roles of small RNA pathways in reproductive medicine. Mol Endocrinol (2011) 0.92
miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes. PLoS One (2013) 0.91
MicroRNAs in cancer diagnosis and therapy: from bench to bedside. Surg Today (2012) 0.90
The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p. Nat Commun (2015) 0.90
Glycolysis in Panc-1 human pancreatic cancer cells is inhibited by everolimus. Exp Ther Med (2012) 0.90
The microRNA and messengerRNA profile of the RNA-induced silencing complex in human primary astrocyte and astrocytoma cells. PLoS One (2010) 0.88
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 82.89
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
MicroRNA signatures in human cancers. Nat Rev Cancer (2006) 46.29
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21
A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09
The nuclear RNase III Drosha initiates microRNA processing. Nature (2003) 35.49
A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03
c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 31.81
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med (2005) 26.02
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell (2006) 23.59
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A (2006) 21.58
miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A (2005) 21.51
MicroRNA genes are transcribed by RNA polymerase II. EMBO J (2004) 20.65
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell (1990) 20.60
The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science (2005) 20.51
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev (2003) 17.64
Estimating the world cancer burden: Globocan 2000. Int J Cancer (2001) 16.92
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol (1988) 16.82
Nuclear export of microRNA precursors. Science (2003) 16.59
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54
Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet (2005) 15.96
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature (2005) 13.44
Phylogenetic shadowing and computational identification of human microRNA genes. Cell (2005) 13.24
Identification of microRNAs of the herpesvirus family. Nat Methods (2005) 12.98
Identification of virus-encoded microRNAs. Science (2004) 12.56
Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell (2006) 11.98
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell (2006) 11.01
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A (2006) 10.65
A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell (2005) 9.22
Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell (2005) 9.01
Transcription and processing of human microRNA precursors. Mol Cell (2004) 8.98
The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A (2005) 8.60
A cellular microRNA mediates antiviral defense in human cells. Science (2005) 8.48
Single processing center models for human Dicer and bacterial RNase III. Cell (2004) 8.19
Genomics of microRNA. Trends Genet (2006) 7.75
Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A (2005) 5.88
SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature (2005) 5.54
Viruses and microRNAs. Nat Genet (2006) 4.54
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology (2008) 4.38
Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. J Natl Cancer Inst Monogr (2003) 4.35
E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res (1996) 4.14
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst (2006) 4.14
Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol (2005) 4.01
Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol (1995) 3.57
Strategies to determine the biological function of microRNAs. Nat Genet (2006) 3.49
Retracted Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature (2006) 3.47
Patterns of known and novel small RNAs in human cervical cancer. Cancer Res (2007) 3.46
Loss of mir-146a function in hormone-refractory prostate cancer. RNA (2008) 3.35
Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer (1989) 3.30
MicroRNAs: regulators of gene expression and cell differentiation. Blood (2006) 3.08
Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J Virol (1992) 2.99
Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol (2007) 2.88
Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A (1995) 2.79
p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene (1991) 2.76
Prediction and identification of herpes simplex virus 1-encoded microRNAs. J Virol (2006) 2.67
Retracted MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem (2006) 2.62
Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci (2007) 2.61
Natural selection drives extremely rapid evolution in antiviral RNAi genes. Curr Biol (2006) 2.50
The contributions of dsRNA structure to Dicer specificity and efficiency. RNA (2005) 2.48
Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene (2007) 2.36
In situ synthesis of oligonucleotide microarrays. Biopolymers (2004) 2.20
Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol (2007) 2.11
Is RNA interference involved in intrinsic antiviral immunity in mammals? Nat Immunol (2006) 2.02
Microfluidic PicoArray synthesis of oligodeoxynucleotides and simultaneous assembling of multiple DNA sequences. Nucleic Acids Res (2004) 1.53
Propagation, infection, and neutralization of authentic HPV16 virus. Virology (2004) 1.32
Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication. J Virol (2006) 1.27
Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39. J Clin Microbiol (1996) 1.26
Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells. Oncogene (2006) 1.18
Propagation of infectious, high-risk HPV in organotypic "raft" culture. Methods Mol Med (2005) 0.98
Innate immune defense through RNA interference. Sci STKE (2006) 0.94
Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell (2008) 5.11
Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity (2005) 3.70
Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol Syst Biol (2010) 3.56
Resource utilization for ovarian cancer patients at the end of life: how much is too much? Gynecol Oncol (2005) 2.26
HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology (2004) 2.23
Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest (2010) 2.19
A microRNA expression signature for cervical cancer prognosis. Cancer Res (2010) 2.14
Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply? Gynecol Oncol (2004) 2.08
Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys (2009) 2.05
Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type. J Clin Oncol (2007) 1.87
Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci U S A (2003) 1.83
Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol (2002) 1.72
Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res (2009) 1.69
Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. Cancer (2005) 1.68
Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA (2009) 1.60
Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors. Gynecol Oncol (2009) 1.59
Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet (2004) 1.57
Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol (2010) 1.55
SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance. Int J Biol Sci (2010) 1.40
Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer (2007) 1.38
Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma. Clin Cancer Res (2003) 1.36
Propagation, infection, and neutralization of authentic HPV16 virus. Virology (2004) 1.32
Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes. J Biol Chem (2009) 1.29
Structural and functional analyses of Kaposi sarcoma-associated herpesvirus ORF57 nuclear localization signals in living cells. J Biol Chem (2006) 1.28
Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility. J Biol Chem (2006) 1.28
Gene structure and expression of Kaposi's sarcoma-associated herpesvirus ORF56, ORF57, ORF58, and ORF59. J Virol (2006) 1.27
Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res (2005) 1.27
In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration. Mol Ther (2010) 1.26
Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PLoS One (2011) 1.26
ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes. J Clin Oncol (2009) 1.25
Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression. J Virol (2011) 1.25
microRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci U S A (2014) 1.25
Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease. Mol Ther (2012) 1.24
The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J Virol (2007) 1.22
Identification of viral microRNAs expressed in human sacral ganglia latently infected with herpes simplex virus 2. J Virol (2009) 1.21
The survey of H5N1 flu virus in wild birds in 14 Provinces of China from 2004 to 2007. PLoS One (2009) 1.21
Control of the papillomavirus early-to-late switch by differentially expressed SRp20. J Virol (2008) 1.20
Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer (2005) 1.20
Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J Virol (2009) 1.18
Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiol Biomarkers Prev (2009) 1.18
Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. Cancer Res (2007) 1.17
Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice. Mol Ther (2008) 1.17
Kaposi's sarcoma-associated herpesvirus K8 exon 3 contains three 5'-splice sites and harbors a K8.1 transcription start site. J Biol Chem (2002) 1.16
Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response. PLoS Pathog (2013) 1.15
Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol (2004) 1.15
Kaposi's sarcoma-associated herpesvirus ORF57 in viral RNA processing. Front Biosci (Landmark Ed) (2009) 1.13
Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol (2011) 1.11
Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence. Int J Radiat Oncol Biol Phys (2005) 1.11
Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122. J Biol Chem (2011) 1.11
Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster. J Virol (2006) 1.11
Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer. Clin Cancer Res (2012) 1.09
Human papillomavirus type 45 propagation, infection, and neutralization. Virology (2003) 1.09
Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. J Pathol (2011) 1.08
Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells. J Virol (2003) 1.08
Requirement of a 12-base-pair TATT-containing sequence and viral lytic DNA replication in activation of the Kaposi's sarcoma-associated herpesvirus K8.1 late promoter. J Virol (2004) 1.08
Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol (2002) 1.08
Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis. Cancer (2006) 1.07
RNA-binding protein HuR interacts with thrombomodulin 5'untranslated region and represses internal ribosome entry site-mediated translation under IL-1 beta treatment. Mol Biol Cell (2008) 1.07
Stability of a long noncoding viral RNA depends on a 9-nt core element at the RNA 5' end to interact with viral ORF57 and cellular PABPC1. Int J Biol Sci (2011) 1.06
Caspase-7 cleavage of Kaposi sarcoma-associated herpesvirus ORF57 confers a cellular function against viral lytic gene expression. J Biol Chem (2010) 1.06
Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer. Gynecol Oncol (2006) 1.05
Variable expression of some "housekeeping" genes during human keratinocyte differentiation. Anal Biochem (2002) 1.03
Kaposi's sarcoma-associated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59. J Virol (2010) 1.03
Could human papillomaviruses be spread through blood? J Clin Microbiol (2005) 1.02
Cervical tissue collection methods for RNA preservation: comparison of snap-frozen, ethanol-fixed, and RNAlater-fixation. Diagn Mol Pathol (2006) 1.02
CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer. Cancer Res (2007) 1.01
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies. Cancer Chemother Pharmacol (2010) 1.01
Overlapping and independent structural roles for human papillomavirus type 16 L2 conserved cysteines. Virology (2009) 1.01
Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway. Int J Cancer (2011) 1.01
DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis. Mod Pathol (2006) 0.99
Evidence for the coexistence of two genital HPV types within the same host cell in vitro. Virology (2004) 0.98
Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Res (2008) 0.98
Propagation of infectious, high-risk HPV in organotypic "raft" culture. Methods Mol Med (2005) 0.98
HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer. Immunogenetics (2010) 0.97
Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol (2002) 0.96
The significance of pneumatosis intestinalis or bowel perforation in patients with gynecologic malignancies. Gynecol Oncol (2002) 0.96
Mapping and characterization of the minimal internal ribosome entry segment in the human c-myc mRNA 5' untranslated region. Oncogene (2004) 0.96
Cervical sarcomas: an analysis of incidence and outcome. Gynecol Oncol (2005) 0.96
Characterization of H5N1 influenza viruses isolated from migratory birds in Qinghai province of China in 2006. Avian Dis (2007) 0.96
Apolipoprotein E protects astrocytes from hypoxia and glutamate-induced apoptosis. FEBS Lett (2012) 0.95
Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter. J Virol (2005) 0.95
Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. Gynecol Oncol (2008) 0.95
The extent of sequence complementarity correlates with the potency of cellular miRNA-mediated restriction of HIV-1. Nucleic Acids Res (2012) 0.94
Evaluation of candidate methylation markers to detect cervical neoplasia. Gynecol Oncol (2007) 0.94
Bevacizumab therapy in patients with recurrent uterine neoplasms. Anticancer Res (2007) 0.94